Time to recovery from severe communityacquired pneumonia and its determinants among older adults admitted to North Wollo hospitals: A multi-centred cohort study.

Background Severe community-acquired pneumonia presents a looming threat<br> to older adults globally, often resulting in alarming mortality rates. Despite advancements in treatment, challenges persist, exacerbated by factors like increasing comorbidity. As age rises, so does the risk of mortality and prolonged recovery periods. Particularly in low-income countries such as Ethiopia, the burden<br> of severe community-acquired pneumonia is staggering. Yet, research on the<br> estimated time to recovery and its determinants among older adults in this region remains insufficient, demanding urgent attention. Hence, in this study we<br> endeavour to uncover insights into the recovery time and contributing factors<br> among older adults.<br> Methods We conducted a multi-centred retrospective cohort study among 422<br> older adults aged &gt;65 years. We collected data using a structured checklist, and<br> the final sample was meticulously selected using a systematic sampling technique. We computed Kaplan-Meier survival curves and log-rank tests to compare survival curves. We assessed multicollinearity using variance inflation<br> factors. Further, we employed a Cox regression model to identify significant<br> determinants, with model fitness evaluated using a Cox-Snell residual plot. Statistical significance was declared at a P≤0.05.<br> Results In this study, 79.3% (95% confidence interval (CI)=75.58–83.29) of<br> patients achieved recovery, with a median time to recovery from severe community-acquired pneumonia of 19 days. Age &gt;75 years, diabetes mellitus, chronic obstructive pulmonary disease, elevated creatinine level and baseline white<br> blood cells greater than 11.0×109/L were found to be significant determinants.<br> Conclusions On average, older adults take 19 days to recover from severe community-acquired pneumonia. Recovery times are notably longer for individuals<br> aged &gt;75 years, those with comorbidities, and those with elevated white blood<br> cell and creatinine levels. Therefore, tailored interventions addressing these specific factors could potentially improve patient outcomes.<br>